JP2010503409A5 - - Google Patents

Download PDF

Info

Publication number
JP2010503409A5
JP2010503409A5 JP2009528468A JP2009528468A JP2010503409A5 JP 2010503409 A5 JP2010503409 A5 JP 2010503409A5 JP 2009528468 A JP2009528468 A JP 2009528468A JP 2009528468 A JP2009528468 A JP 2009528468A JP 2010503409 A5 JP2010503409 A5 JP 2010503409A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cancer
composition according
peptide
azurin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009528468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010503409A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/078371 external-priority patent/WO2008033987A2/en
Publication of JP2010503409A publication Critical patent/JP2010503409A/ja
Publication of JP2010503409A5 publication Critical patent/JP2010503409A5/ja
Withdrawn legal-status Critical Current

Links

JP2009528468A 2006-09-14 2007-09-13 クプレドキシンによって癌を予防する組成物および方法 Withdrawn JP2010503409A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013209725A Division JP2014050390A (ja) 2006-09-14 2013-10-04 クプレドキシンによって癌を予防する組成物および方法

Publications (2)

Publication Number Publication Date
JP2010503409A JP2010503409A (ja) 2010-02-04
JP2010503409A5 true JP2010503409A5 (https=) 2010-11-04

Family

ID=39184582

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009528468A Withdrawn JP2010503409A (ja) 2006-09-14 2007-09-13 クプレドキシンによって癌を予防する組成物および方法
JP2013209725A Pending JP2014050390A (ja) 2006-09-14 2013-10-04 クプレドキシンによって癌を予防する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013209725A Pending JP2014050390A (ja) 2006-09-14 2013-10-04 クプレドキシンによって癌を予防する組成物および方法

Country Status (13)

Country Link
EP (1) EP2061498A4 (https=)
JP (2) JP2010503409A (https=)
KR (1) KR20090059152A (https=)
CN (1) CN101595124A (https=)
AU (1) AU2007296429A1 (https=)
BR (1) BRPI0714987A2 (https=)
CA (1) CA2663498A1 (https=)
IL (1) IL197602A0 (https=)
MX (1) MX2009002787A (https=)
NO (1) NO20091267L (https=)
RU (1) RU2009113812A (https=)
SG (1) SG174784A1 (https=)
WO (1) WO2008033987A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
EA200700813A1 (ru) 2004-10-07 2008-10-30 Ананда Чакрабарти Транспортирующие вещества, производные купредоксина и способы их применения
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
CA2615617A1 (en) 2005-07-19 2007-01-25 The Board Of Trustees Of The University Of Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
JP2010511408A (ja) * 2006-12-04 2010-04-15 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 癌をCpGリッチDNAおよびキュプレドキシンで治療するための組成物および方法
JP2010518123A (ja) * 2007-02-08 2010-05-27 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 癌をキュプレドキシンで予防するための組成物および方法
KR102718038B1 (ko) 2017-09-29 2024-10-16 온크그노스틱스 게엠베하 신생물증 및 암에 대한 위험 결정

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
EA200700813A1 (ru) * 2004-10-07 2008-10-30 Ананда Чакрабарти Транспортирующие вещества, производные купредоксина и способы их применения
AU2006277009A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2007024368A2 (en) * 2005-07-19 2007-03-01 The Board Of Trustees Of The University Of Illinois Compositions and methods to control angiogenesis with cupredoxins

Similar Documents

Publication Publication Date Title
JP2010503409A5 (https=)
RU2009113812A (ru) Композиции и способы для профилактики рака с помощью купредоксинов
CA2437983C (en) Transporters comprising spaced arginine moieties
US6669951B2 (en) Compositions and methods for enhancing drug delivery across and into epithelial tissues
RU2009133473A (ru) Композиции и способы для предотвращения рака с помощью купредоксинов
ES2989204T3 (es) Pautas posológicas para la administración de análogos del péptido 2 similar al glucagón (GLP-2)
RU2009125599A (ru) Композиции и способы лечения рака cpg-богатой днк и купредоксинами
KR102741242B1 (ko) 국소 조성물 및 용도
NZ587105A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
CY1117759T1 (el) Ενα καινουργιο φαρμακευτικο παρασκευασμα για την προ-εκλαμψια
AU2018389121A1 (en) Botulinum toxin cell binding domain polypeptides and methods of use for treatments of fibrosis associated disorders
JP2014050390A5 (https=)
EP3480212B1 (en) Il13ralpha2 peptide and its uses
RU2016116708A (ru) Олигопептиды металлопротеиназ и их терапевтическое применение
BRPI0810384B1 (pt) terapia enzimática anticâncer
CA3148827A1 (en) Compositions and methods of using c/ebp alpha sarna
WO2004108088A3 (en) Methods and compositions for interferon therapy
JP2014531469A (ja) Kv1.3カリウムチャネルの薬理学的標的化による肥満症および肥満症関連障害の治療
US20200188451A1 (en) OXALOBACTER FORMIGENES (Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS
CN106924260B (zh) 化合物在制备用于治疗脑胶质瘤的药物中的用途
TWI496579B (zh) 類鋅手指胜肽、其表現質體、及包含其之醫藥組成物之用途
ES2842523T3 (es) Métodos y composiciones para el tratamiento de la artritis
JP2022535086A (ja) 修飾ペプチドおよび関連する使用方法
US10793601B2 (en) Therapeutic spalt-like transcription factor 4 (SALL4) peptide
CN114364691B (zh) 作为纤维化基质积累的抑制剂的肽